
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
Ethics Group Calls on FTC to Investigate Drug Pricing
The Citizens for Responsibility and Ethics in Washington, a nonprofit organization dedicated to promoting ethics and accountability, sent a






